NCT00699777 - Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2008

Conditions

Osteoporosis

Interventions

DRUG

Risedronate

1 risedronate 150 mg tablet administered orally

DRUG

Risedronate

2 risedronate 75 mg tablets administered as a single oral dose

Trial Locations (4)

Research Site, Gainesville

Research Facility, Miramar

Research Facility, Austin

Research Facility, Dallas